Title |
Slashing the timelines: Opting to generate high‐titer clonal lines faster via viability‐based single cell sorting
|
---|---|
Published in |
Biotechnology Progress, December 2015
|
DOI | 10.1002/btpr.2204 |
Pubmed ID | |
Authors |
Shahram Misaghi, David Shaw, Salina Louie, Adrian Nava, Laura Simmons, Brad Snedecor, Chungkee Poon, Jonathan S Paw, Laurie Gilmour-Appling, James E Cupp |
Abstract |
Chinese hamster ovary (CHO) cell line development (CLD) is a long and laborious process, which requires up to 5-6 months in order to generate and bank CHO lines capable of stably expressing therapeutic molecules. Additionally, single cell cloning of these production lines is also necessary to confirm clonality of the production lines. Here we introduce the utilization of viability staining dye in combination with flow cytometer to isolate high titer clones from a pool of selected cells and single cell deposit them into the wells of culture plates. Our data suggests that a stringent selection procedure along with viability dye staining and flow cytometry-based sorting can be used to isolate high expressing clones with titers comparable to that of traditional CLD methods. This approach not only requires less labor and consumables, but it also shortens CLD timelines by at least 3 weeks. Furthermore, single cell deposition of selected cells by a flow sorter can be regarded as an additional clonality assurance factor that in combination with Day 0 imaging can ensure clonality of the production lines. This article is protected by copyright. All rights reserved. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 33% |
Student > Ph. D. Student | 7 | 18% |
Student > Master | 5 | 13% |
Other | 4 | 10% |
Student > Postgraduate | 2 | 5% |
Other | 2 | 5% |
Unknown | 6 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 15 | 38% |
Biochemistry, Genetics and Molecular Biology | 13 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Medicine and Dentistry | 2 | 5% |
Chemical Engineering | 1 | 3% |
Other | 1 | 3% |
Unknown | 5 | 13% |